Cornelia Lass-Flörl
Univ.Prof. Dr.med.univ.
Direktorin des Institutes für Hygiene und Medizinische Mikrobiologie
Facharzt für Hygiene und Mikrobiologie
Schwerpunkt: Mykologie und Krankenhaushygiene
Direktorin des CD-Labors für invasive Pilzinfektionen
European Excellence Center of Medical Mycology (ECMM)
Tel.: +43 (0)512 9003-70700
Fax: +43 (0)512 9003-73700
E-Mail: cornelia.lass-floerl@i-med.ac.at
Curriculum Vitae
|
1992
|
Dr. med univ. (M.D.), Medical School, University of Innsbruck |
|
2000
|
Medical Specialisation (Facharzt) for Hygiene and Microbiology |
| 2001 | Habilitation for "Hygiene, Microbiology and Preventive Medicine" Habilitation thesis: "Epidemiology and prevention of nosocomial aspergillosis" |
|
2002
|
Associate Professor at the Institute of Hygiene and Social Medicine, Univ. Innsbruck |
| 2009 | Chair offer (1st Place) Vienna Medical University; Institute of Hygiene and Medical Microbiology |
| 2009 | Chair offer (1st Place) Innsbruck Medical University; Institute of Hygiene and Medical Microbiology |
| 2010 | Head of the Institute of Hygiene and Medical Microbiology |
Offices and career-related activities
| 2003- | Member of the Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) |
| 2004- | Member of the Editorial Board "Mycoses" |
| 2004-2012 | Austrian Delegate of the European Confederation of Medical Mycology |
| 2007-2012 | Vice president of the Austrian Society of Medical Mycology |
| 2007-2012 | Member of the Executive Board (Secretary) of the EFISG ESCMID Fungal Infection Study Group |
| 2007-2009 | Member of the Editorial Board "Current Fungus Infection Reports" |
| 2007- | Coordinator of the ISHAM Aspergillus Working group |
| 2008-2012 | Member of the Executive Board (Treasurer) of the European Confederation of Medical Mycology |
| 2008-2011 | Head "Sektion Antimykotische Chemotherapie", Paul-Ehrlich-Gesellschaft |
| 2009-2012 | Member of the University Board, Graz Medical University |
| 2009- | Member of the Executive Board of the ÖGHMP |
| 2010- | Member of the Executive Board of the ÖGIT |
| 2012-2016 | Member of Executive Committee of the European Society of Medical Microbiology and Infectious Diseases (ESCMID) |
| 2014- | Member of the scientific advisory board "The Iceman" |
| 2016- | Chair of the Executive Board of the European Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases |
| 2016- | Chair of the ECMM Excellence Centers Subcommittee |
| 2016 | Infectious Diseases Society of America, Fellow |
| 2017 | European Confederation of Medical Mycology Academy, Fellow |
| 2017 | ESCMID, Fellow |
| 2017 | "Die meistzitierten Köpfe" im deutschsprachigen Raum, Publikationsanalyse 2011-2015: Mikrobiologie, Laborjournal 09/2017 |
| 2018 | Designation of ECMM Excellence Centre |
| 2020 | List of highly cited researchers (Datenkonzern Clarivate) |
| 2020 | American Academy of Microbiology, Fellow |
Research Grants:
Gilead Fund: Serumspiegel unter Amphocil
Pfizer Fund: In vitro susceptibility of Candida and Aspergillus against Voriconazole. The interaction of sertraline on Aspergillus
Austrian Science Fund: Interaction of serotonin and sertraline, 2005
MFT: Thrombocytopenia as risk factor of invasive aspergillosis, 2008-2010
MFT: Aspergillus terreus and amphotericin B resistance
Aesca Grant: Fungal infections - the role of real time PCR
MSD Grant: Study on thrombocyte adherence during interaction with Aspergillus
Unrestricted Basilea Grant: Azole resistance in fungi
MFI-IKFTZ: Platelets attack fungal mitochondriae
Gilead Fund: Antifungal Susceptibility in Aspergillus and rare molds
Pfizer Fund: Antifungal Susceptibility in Aspergillus and rare molds
EU-ECMM: IMD-cross sectional point prevanelt study
Pfizer Fund: Perspective and multicentric clinical evaluation of beta-D-glucan assay in solid organ transplant recipients using blood and BAL samples
Pfizer Fund: An Austrian experience with anidulafungin in clinical practice: A multicenter study - Part I
Pfizer Fund: An Austrian experience with anidulafungin in clinical practice: A multicenter study - Part II
Austrian Science Fund: Oxystress and human fungal pathogens: clinical and applied aspects
Austrian Science Fund: Biomarker and antifungal resistance in Aspergillus
Astellas Science Fund: Micafungin De-escalation Study
ECMM & ISHAM: Aspergillus terreus - TerrNet epidemiology worldwide
Austrian Science Fund: Host Response in Opportunistic Infections (HOROS) - doctoral programme of excellence
Christian Doppler Gesellschaft: CD laboratory for fungal infections: avoid, find and treat
H2020-MSCA-ITN: OPATHY ETN
Austrian Science Fund: Novel Biomarker in Invasive Candidiasis/Candida Sepsis